Beta Pharma, Inc. Email Format
Pharmaceutical ManufacturingNew Jersey, United States11-50 Employees
Beta Pharma, Inc. operates in the pharmaceutical manufacturing sector with a focus on oncology, pursuing discovery, development, and commercialization of late-stage therapies. The company describes its pipeline as diverse and rapidly developing. It originated in 1996 as Beta Chemicals Inc., a contract research organization founded at Yale's Science Park to provide custom synthesis for the pharma and biotech R&D community, and it is based in Princeton, New Jersey. A notable program is Icotinib, an EGFR inhibitor that entered Phase I trials in China in 2006 and received SFDA approval in 2011, with global registration pursued through regional partnerships worldwide. The organization is a relatively small firm concentrating its operations in the United States.